Trial intelligence / Profile preview

Decitabine + BUCY vs BUCY in MLL-Rearranged Acute Leukemia

NCT03596892Phase 3Unknown

Sponsor
Nanfang Hospital, Southern Medical University
Start
Jul 2018
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of decitabine in acute leukemia, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.

02

Drugs

decitabine
03

Conditions

acute leukemia

Beyond the preview

Go deeper on NCT03596892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03596892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call